Dimensional Fund Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-118,608
| Closed | -$383K | – | 3392 |
|
2023
Q4 | $383K | Sell |
118,608
-8,669
| -7% | -$28K | ﹤0.01% | 3086 |
|
2023
Q3 | $676K | Sell |
127,277
-15,322
| -11% | -$81.4K | ﹤0.01% | 2998 |
|
2023
Q2 | $1.36M | Sell |
142,599
-295,516
| -67% | -$2.81M | ﹤0.01% | 2872 |
|
2023
Q1 | $4.82M | Buy |
438,115
+67,625
| +18% | +$744K | ﹤0.01% | 2496 |
|
2022
Q4 | $5.48K | Buy |
370,490
+56,547
| +18% | +$837 | ﹤0.01% | 2419 |
|
2022
Q3 | $6M | Buy |
313,943
+1,335
| +0.4% | +$25.5K | ﹤0.01% | 2361 |
|
2022
Q2 | $6.66M | Buy |
312,608
+85,225
| +37% | +$1.82M | ﹤0.01% | 2360 |
|
2022
Q1 | $4.38M | Buy |
227,383
+103,477
| +84% | +$1.99M | ﹤0.01% | 2577 |
|
2021
Q4 | $2.57M | Buy |
123,906
+44,511
| +56% | +$923K | ﹤0.01% | 2787 |
|
2021
Q3 | $1.89M | Buy |
79,395
+32,616
| +70% | +$778K | ﹤0.01% | 2869 |
|
2021
Q2 | $1.28M | Buy |
+46,779
| New | +$1.28M | ﹤0.01% | 2980 |
|